Literature DB >> 15939218

The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.

Pablo Martínez-Martín1, Julián Benito-León, Juan A Burguera, Alfonso Castro, Gurutz Linazasoro, Juan C Martínez-Castrillo, Francesc Valldeoriola, Antonio Vázquez, Francisco Vivancos, Javier del Val, Nadèje van Blercom, Belén Frades.   

Abstract

OBJECTIVE: The SCOPA-Motor Scale (S-MS) for assessment of Parkinson's disease (PD), contains 21 items in three domains: Motor examination, Disability, and Complications. Our objective was to validate the S-MS Spanish version. STUDY DESIGN AND
SETTING: This validation study was based on a multicenter, cross-sectional, one-point-in-time evaluation design. The applied measures were: Unified Parkinson's Disease Rating Scale-3.0 (UPDRS); S-MS; PD Global Evaluation (PDGE); and Clinical Global Impression of severity (CGI). Completeness of data collection, floor and ceiling effect, internal consistency, precision, and construct and discriminative validity were analyzed in 151 PD patients.
RESULTS: Scores from S-MS were fully computable. Floor effect was high for Complications (43.7%). Cronbach's alpha was > 0.90 for every domain, and item-total correlation was > 0.70 except for Examination. Standard error of measurement (SEM) ranged from 0.40 to 2.4. Convergent validity with corresponding UPDRS sections yielded coefficients > 0.90. Discriminative validity across Hoehn and Yahr (HY) and CGI stages was significant (Kruskal-Wallis, P < .0001). Insofar as internal consistency was concerned, alpha-values of the Examination sections were marginally higher for the UPDRS than for the S-MS (a finding perhaps accounted for by redundancy in this part of the UPDRS).
CONCLUSION: The S-MS is a consistent and valid scale, shorter by almost half than the UPDRS.

Entities:  

Mesh:

Year:  2005        PMID: 15939218     DOI: 10.1016/j.jclinepi.2004.09.014

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  17 in total

1.  Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.

Authors:  Jennifer Y Y Szeto; Courtney C Walton; Alexandra Rizos; Pablo Martinez-Martin; Glenda M Halliday; Sharon L Naismith; K Ray Chaudhuri; Simon J G Lewis
Journal:  NPJ Parkinsons Dis       Date:  2020-01-07

2.  A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach.

Authors:  Pablo Martinez-Martin; Belen Frades-Payo; Luis Agüera-Ortiz; Angel Ayuga-Martinez
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

3.  Predictors of anxiety in Parkinson's disease: results from a 3-year longitudinal cohort study.

Authors:  Jessie S Gibson; Joseph L Flanigan; James T Patrie; W Alex Dalrymple; Madaline B Harrison
Journal:  Neurol Sci       Date:  2022-10-11       Impact factor: 3.830

4.  Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Cristian Falup Pecurariu; Per Odin; Jacobus J van Hilten; Angelo Antonini; Jose M Rojo-Abuin; Vanderci Borges; Claudia Trenkwalder; Dag Aarsland; David J Brooks; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

5.  Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.

Authors:  Laurie K Mischley; Richard C Lau; Noel S Weiss
Journal:  NPJ Parkinsons Dis       Date:  2017-06-16

6.  A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.

Authors:  Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; David J Brooks; Fabrizio Stocchi; Per Odin; Angelo Antonini; Richard G Brown; Richard J Brown; Pablo Martinez-Martin
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

7.  Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson's Disease.

Authors:  Francisco Torres; Esteban Villalon; Patricio Poblete; Rodrigo Moraga-Amaro; Sergio Linsambarth; Raúl Riquelme; Abraham Zangen; Jimmy Stehberg
Journal:  Front Neurol       Date:  2015-10-26       Impact factor: 4.003

Review 8.  Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?

Authors:  K Ray Chaudhuri; Alexandra Rizos; Kapil D Sethi
Journal:  J Neural Transm (Vienna)       Date:  2013-03-02       Impact factor: 3.575

9.  Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.

Authors:  Jesse Mu; Kallol R Chaudhuri; Concha Bielza; Jesus de Pedro-Cuesta; Pedro Larrañaga; Pablo Martinez-Martin
Journal:  Front Aging Neurosci       Date:  2017-09-20       Impact factor: 5.750

10.  Living with chronic illness scale: international validation of a new self-report measure in Parkinson's disease.

Authors:  Leire Ambrosio; Mari Carmen Portillo; Carmen Rodríguez-Blázquez; Mayela Rodriguez-Violante; Juan Carlos Martínez Castrillo; Víctor Campos Arillo; Nélida Susana Garretto; Tomoko Arakaki; Marcos Serrano Dueñas; Mario Álvarez; Ivonne Pedroso Ibáñez; Ana Carvajal; Pablo Martínez-Martín
Journal:  NPJ Parkinsons Dis       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.